Clindamycin 1% Nano-emulsion Gel Formulation for the Treatment of Acne Vulgaris: Results of a Randomized, Active Controlled, Multicentre, Phase IV Clinical Trial | Zendy

Bhavik A. Bhavsar | Zendy; Bimal Choksi | Zendy; Jayesh Sanmukhani | Zendy; Alka Dogra | Zendy; Rizwan ul Haq | Zendy; Sudhanshu Mehta | Zendy; Santanu Mukherjee | Zendy; Valavanur A. Subramanian | Zendy; Sheikh Shafiq | Zendy; Ravindra Mittal | Zendy

Open Access

Clindamycin 1% Nano-emulsion Gel Formulation for the Treatment of Acne Vulgaris: Results of a Randomized, Active Controlled, Multicentre, Phase IV Clinical Trial

Author(s) -

Bhavik A. Bhavsar,

Bimal Choksi,

Jayesh Sanmukhani,

Alka Dogra,

Rizwan ul Haq,

Sudhanshu Mehta,

Santanu Mukherjee,

Valavanur A. Subramanian,

Sheikh Shafiq,

Ravindra Mittal

Publication year - 2014

Publication title -

journal of clinical and diagnostic research

Language(s) - English

Resource type - Journals

eISSN - 2249-782X

pISSN - 0973-709X

DOI - 10.7860/jcdr/2014/9111.4769

Subject(s) - acne , tolerability , medicine , clinical trial , randomized controlled trial , dermatology , adverse effect

Acne vulgaris of the face is a common dermatological disease with a significant impact on the quality of life, psychosocial development as well as self-esteem of the patients. Nano emulsion gel formulations are said to have various advantages over the conventional formulations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research